Meloxicam: Clinical Trials

24 trials of Meloxicam, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 5 unknown, 3 withdrawn, 1 not yet recruiting. 24 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 324Completed 15, Unknown 5, Withdrawn 3, Not yet recruiting 1
Phase 22Completed 1, Unknown 1

Follow Meloxicam: new trials by email Literature Review of Meloxicam trials Research Report on Meloxicam

Trials (filtered) newest first · largest first

All 24 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service
TPS-Select, Pharmacologic Pain Management, Interventional Pain Procedures - Postsurgical Pain Management, Postsurgical Pain, Chronic
Phase 3Not yet recruitingUniversity of California, San Francisco4742026-10-012026-10-09
Efficacy and Safety of Etoricoxib+Diacerein in Osteoarthritis.
Etoricoxib 90 mg + diacerein 50 mg, Meloxicam 15 mg + diacerein 50 mg - Pain Management, Osteoarthritis
Phase 3CompletedLaboratorios Liomont1232024-05-242026-04-29
Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-severe Pain Following Abdominal Surgery
Meloxicam Injection, Sodium Chloride Injection - Participants With Acute Moderate to Severe Pain Following Abdominal Surgery
Phase 3CompletedYangtze River Pharmaceutical Group Co., Ltd.2242024-01-292025-04-01
Pain Relief After PrimaryTKA
Zynrelef (Bupivacaine 60 MG / Meloxicam 1.8 MG) Per 2.3 ML Extended Release Solution, Bupivacaine HCl 0.5% Injectable Solution, primary total knee replacement - Pain, Postoperative
Phase 3UnknownRothman Institute Orthopaedics602023-02-282023-03-02
Meloxicam for Pain Management After Total Joint Arthroplasty (TJA)
IV meloxicam, Ketorolac - Total Knee Replacement, Total Hip Replacement
Phase 3CompletedUniversity of Miami2232022-05-012024-08-14
Does Meloxicam Provide as Much Pain Relief as Opioids After Shoulder Surgery?
Meloxicam 15 mg, Preoperative Interscalene Nerve Block, arthroscopic labral repair - Shoulder Pain
Phase 3UnknownRothman Institute Orthopaedics962021-01-252021-01-26
Maximizing Outcomes in Treating Acute Migraine
AXS-07 (MoSEIC meloxicam and rizatriptan), Meloxicam, Rizatriptan - Migraine
Phase 3CompletedAxsome Therapeutics, Inc.15942019-03-042023-08-24
A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical Study
glucosamine sulphate 1500mg and meloxicam 15mg, Glucosamine sulfate 1500mg and chondroitin sulfate 1200mg, Placebos - Knee Osteoarthritis
Phase 3WithdrawnEurofarma Laboratorios S.A.2019-01-012022-04-18
Multimodal Analgesia in Shoulder Arthroplasty
Acetaminophen, Celecoxib 200mg, Celecoxib 400 mg - Shoulder Pain, Opioid Use
Phase 3WithdrawnRush University Medical Center2018-06-012021-09-28
Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis
Bawei Shenqi Pill, Bawei Shenqi Pill placebo, Meloxicam - Ankylosing Spondylitis
Phase 2 / Phase 3UnknownShanghai University of Traditional Chinese Medicine802017-10-012020-08-14
Study of Association of Anti-inflammatory and Anti-rheumatic
Meloxicam and Glucosamine, Meloxicam, Glucosamine - Osteoarthritis
Phase 3UnknownZodiac Produtos Farmaceuticos S.A.3752015-07-012015-05-19
Assessment of a Vaginal Ring With Meloxicam in the Treatment of Dysmenorrhea
Meloxicam, Diclofenac Potassium, Placebo Oral - Dysmenorrhea
Phase 2 / Phase 3CompletedLaboratorios Andromaco S.A.682014-06-272019-05-03
TB-IRIS NSAID Cox-2 Inhibitor Prevention Trial
Meloxicam 7.5mg daily for 8 weeks - Tuberculosis
Phase 3UnknownUniversity of Stellenbosch2002014-04-012014-04-03
Improving Pain Management and Long Term Outcomes Following High Energy Orthopedic Trauma (Pain Study)
NSAID, Gabapentinoids, placebo - Orthopaedic Fractures
Phase 3CompletedMajor Extremity Trauma Research Consortium4502013-07-012026-11-13
Study Comparing A New Drug Containing The Combination Meloxicam And Cyclobenzaprine In The Treatment Of Acute Lumbago
meloxicam/cyclobenzaprine hydrochloride, meloxicam - MovatecĀ®, cyclobenzaprine - MiosanĀ® - Acute Lumbago
Phase 3WithdrawnEurofarma Laboratorios S.A.2013-05-012016-05-03
Treatment of Recent Onset Low Back Pain With Periradicular Injections of Meloxicam
saline, Meloxicam - Low Back Pain
Phase 3CompletedIstituto Ortopedico Rizzoli802012-05-012023-05-12
Efficacy and Safety of Injectable Association of Dexamethasone, Dipyrone and Hydrocobalamin in Lumbar Sciatic Pain
Dextralgen, Meloxicam - Lumbar Sciatic Pain
Phase 3CompletedEurofarma Laboratorios S.A.2802011-02-012025-03-28
A Study to Compare Meloxicam IM Once Daily and Meloxicam Administered Orally Once Daily in Patients With Osteoarthritis
Meloxicam ampoule, Meloxicam tablet - Osteoarthritis
Phase 3CompletedBoehringer Ingelheim1682004-07-012013-11-01
A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis
Meloxicam ampoule, Meloxicam tablet - Arthritis, Rheumatoid
Phase 3CompletedBoehringer Ingelheim1502004-07-012018-08-03
Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy
Meloxicam - Prostatic Neoplasms
Phase 3CompletedUniversity Health Network, Toronto1002004-02-012010-08-13

Showing 20 of 24. Sign in to see all of them.

Conditions studied

Osteoarthritis (4)  ·  Arthritis, Rheumatoid (2)  ·  Pain (2)  ·  Pain, Postoperative (2)  ·  Shoulder Pain (2)  ·  Spondylitis, Ankylosing (2)  ·  Acute Pain (1)  ·  Agnosia (1)  ·  Arthritis, Juvenile (1)  ·  Chronic Pain (1)  ·  Dysmenorrhea (1)  ·  Low Back Pain (1)  ·  Lymphoma, Follicular (1)  ·  Migraine Disorders (1)  ·  Osteoarthritis, Knee (1)

Sponsors

Boehringer Ingelheim (6)  ·  Eurofarma Laboratorios S.A. (3)  ·  Rothman Institute Orthopaedics (2)  ·  Axsome Therapeutics, Inc. (1)  ·  Istituto Ortopedico Rizzoli (1)  ·  Laboratorios Andromaco S.A. (1)  ·  Laboratorios Liomont (1)  ·  Major Extremity Trauma Research Consortium (1)  ·  Rush University Medical Center (1)  ·  Shanghai University of Traditional Chinese Medicine (1)  ·  University Health Network, Toronto (1)  ·  University of California, San Francisco (1)  ·  University of Miami (1)  ·  University of Stellenbosch (1)  ·  Yangtze River Pharmaceutical Group Co., Ltd. (1)

Countries

United States (8)  ·  China (4)  ·  Brazil (3)  ·  Italy (3)  ·  Belgium (2)  ·  Canada (2)  ·  France (2)  ·  Germany (2)  ·  Russia (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Chile (1)  ·  Hungary (1)  ·  Mexico (1)

Top investigators

Alceu Chueiri (1)  ·  Andrew Bishara, MD (1)  ·  Antonio Carlos Ximenes (1)  ·  Antonio Scotton (1)  ·  Carlos Gorios, Phd./MD (1)  ·  Carlos Roberto Galia (1)  ·  Edio Costa, Doctor (1)  ·  Gregory P Nicholson, MD (1)  ·  Juanita Crook, MD (1)  ·  Katherine Frey, RN, MPH, MS (1)

Results publications

PMID 20350785, PMID 41167538